Cryo Cell International (CCEL) Gains from Investment Securities (2016 - 2025)
Cryo Cell International's Gains from Investment Securities history spans 15 years, with the latest figure at $103000.0 for Q3 2025.
- Quarterly results put Gains from Investment Securities at $103000.0 for Q3 2025, changed 0.0% from a year ago — trailing twelve months through Feb 2026 was $328200.0 (up 218.64% YoY), and the annual figure for FY2025 was $116218.0, changed 0.0%.
- Gains from Investment Securities for Q3 2025 was $103000.0 at Cryo Cell International, roughly flat from $103000.0 in the prior quarter.
- In the past five years, Gains from Investment Securities ranged from a high of $1.9 million in Q4 2023 to a low of -$2.4 million in Q4 2022.
- The 5-year median for Gains from Investment Securities is $103000.0 (2024), against an average of $71811.8.
- The sharpest move saw Gains from Investment Securities tumbled 248.79% in 2022, then skyrocketed 2886.04% in 2025.
- Year by year, Gains from Investment Securities stood at $1.6 million in 2021, then tumbled by 248.79% to -$2.4 million in 2022, then surged by 177.67% to $1.9 million in 2023, then tumbled by 82.4% to $331897.0 in 2024, then plummeted by 68.97% to $103000.0 in 2025.
- According to Business Quant data, Gains from Investment Securities over the past three periods came in at $103000.0, $103000.0, and $103000.0 for Q3 2025, Q2 2025, and Q1 2025 respectively.